Emma Di Carlo

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Venues

Journal for immunotherapy of cancer

Journal of experimental & clinical cancer research : CR

Cancers

Experimental & molecular medicine

Università degli Studi "G. d'Annunzio" di Chieti-Pescara

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Università degli Studi "G. d'Annunzio" di Chieti-Pescara

Italy

Full Professor :: Dipartimento di Medicina e Scienze dell'Invecchiamento

Publications

Cristiano Fieni, Carlo Sorrentino, Stefania Livia Ciummo, Antonella Fontana, Lavinia Vittoria Lotti, Sofia Scialis, Darien Calvo Garcia, Massimo Caulo, Emma Di Carlo
Immunoliposome-based targeted delivery of the CRISPR/Cas9gRNA-IL30 complex inhibits prostate cancer and prolongs survival. Experimental & molecular medicine (2024)
Emma Di Carlo, Carlo Sorrentino
The multifaceted role of the stroma in the healthy prostate and prostate cancer. Journal of translational medicine 22 (1) (2024)
Stefania Livia Ciummo, Carlo Sorrentino, Cristiano Fieni, Emma Di Carlo
Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways. Journal of experimental & clinical cancer research : CR 42 (1) (2023)
Luigi D'Antonio, Cristiano Fieni, Stefania Livia Ciummo, Simone Vespa, Lavinia Lotti, Carlo Sorrentino, Emma Di Carlo
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival. Journal for immunotherapy of cancer 11 (3) (2023)
Luigi D'Antonio, Cristiano Fieni, Stefania Livia Ciummo, Simone Vespa, Lavinia Lotti, Carlo Sorrentino, Emma Di Carlo
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival. Journal for immunotherapy of cancer 11 (3) (2023)
Carlo Sorrentino, Emma Di Carlo
Molecular Targeted Therapies in Metastatic Prostate Cancer: Recent Advances and Future Challenges. Cancers 15 (11) (2023)
Luigi D'Antonio, Cristiano Fieni, Stefania Livia Ciummo, Simone Vespa, Lavinia Lotti, Carlo Sorrentino, Emma Di Carlo
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival. Journal for immunotherapy of cancer 11 (3) (2023)
Eva Andreuzzi, Albina Fejza, Maurizio Polano, Evelina Poletto, Lucrezia Camicia, Greta Carobolante, Giulia Tarticchio, Federico Todaro, Emma Di Carlo, Melania Scarpa, Melania Scarpa, Alice Paulitti, Alessandra Capuano, Vincenzo Canzonieri, Stefania Maiero, Mara Fornasarig, Renato Cannizzaro, Roberto Doliana, Alfonso Colombatti, Paola Spessotto, Maurizio Mongiat
Colorectal cancer development is affected by the ECM molecule EMILIN-2 hinging on macrophage polarization via the TLR-4/MyD88 pathway. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Carlo Sorrentino, Stefania Livia Ciummo, Luigi D'Antonio, Cristiano Fieni, Paola Lanuti, Alice Turdo, Matilde Todaro, Emma Di Carlo
Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome. Journal for immunotherapy of cancer 9 (10) (2022)
Carlo Sorrentino, Stefania Livia Ciummo, Luigi D'Antonio, Paola Lanuti, Scott I Abrams, Zhinan Yin, Li-Fan Lu, Emma Di Carlo
Hindering triple negative breast cancer progression by targeting endogenous interleukin-30 requires IFNγ signaling. Clinical and translational medicine 11 (2) (2021)
Carlo Sorrentino, Zhinan Yin, Stefania Ciummo, Paola Lanuti, Li-Fan Lu, Marco Marchisio, Matteo Bellone, Emma Di Carlo
Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival. Journal for immunotherapy of cancer 7 (1) (2019)

Emma Di Carlo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Emma Di Carlo